Approval · Notice of Compliance 24028 · 2020
CEFA-DRI: Notice of Compliance 24028
Issued August 13, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24028
- Date
- August 13, 2020
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFA-DRI | 02173255 | Marketed |
Medicinal ingredients
- CEPHAPIRIN BENZATHINE 300 MG per ML